Agilent “Dialogues in CDx” Podcast Series

Episode 8: PD L1 and Beyond in Head & Neck Cancer - Innovation, AI, and What Comes Next

In the eighth episode of Agilent’s Dialogues in CDx, our guests from episode 7 continue the conversation on head and neck cancers with a more forward‑looking perspective.

Episode 7: PD-L1 Testing in Head & Neck Cancer - Current Practice and Clinical Impact

In Episode 7 of Agilent’s Dialogues in CDx, we turn our focus to recent advances in head and neck cancers, a field marked by rapid evolution in diagnostics and clinical d

Episode 6: PD-L1 Prevalence - Reconciling clinical data with real world data

In episode number 6 of Agilent’s “Dialogues in CDx” podcast, we explore how to bridge the gap between clinical data and the realities of daily laboratory practice. To unp

Episode 5: Interpretation of CDx markers - How do we ensure proper training?

In the fifth episode of Agilent’s “Dialogues in CDx” podcast, we discuss how to ensure proper training for PD-L1 interpretation. Two leaders who are shaping this space di

Episode 4: Tissue issues - Overcoming sample limitations for PD-L1 testing

In the fourth episode of the “Dialogues in CDx” podcast series, we explore the issue of sample limitations and how pathologists can address them when performing PD-L1 tes

Episode 3: The Pathologist-Oncologist Connection - Optimal Reporting of the PD-L1 Results

In this third episode of the "Dialogues in CDx" podcast series, you’ll listen to the distinguished guests Dr. Phillippe Taniere and Dr. Shobhit Baijal once more. The prev

Episode 1: A Look Behind the Scenes - Extracting Cutoff and Scoring Algorithms from Clinical Data Title

In this inaugural episode of the "Dialogues in CDx" podcast series, you’ll hear about the intricate relationship between diagnostic cutoffs and clinical data. In the PD-L

Episode 2: Resection to Report - The PD-L1 Testing Journey

The second episode of the "Dialogues in CDx" podcast series takes a closer look at the PD-L1 testing journey. Using England as example, you’ll learn about the process fro

Trailer: Welcome to the "Dialogues in CDx" Podcast

In this new podcast series, Agilent brings together leading pathologists, oncologists, and CDx specialists to explore key challenges and solutions in the field of compani